Voss, L., Guttek, K., Reddig, A., Reinhold, A., Voss, M., Schraven, B., & Reinhold, D. (2021). Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation. Front Immunol.

Voss, Linda, Karina Guttek, Annika Reddig, Annegret Reinhold, Martin Voss, Burkhart Schraven, and Dirk Reinhold. "Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil As Highly Potent Inhibitor of T Cell Proliferation." Front Immunol 2021.

Voss, Linda, et al. "Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil As Highly Potent Inhibitor of T Cell Proliferation." Front Immunol 2021.